End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25,893 MXN | -.--% |
|
-.--% | -.--% |
10:32am | European shares rise ahead of crucial US inflation data | RE |
09:00am | European shares rise ahead of US inflation figures | RE |
Strengths
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- The opinion of analysts covering the stock has improved over the past four months.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company does not generate enough profits, which is an alarming weak point.
- With an expected P/E ratio at 31.18 and 23.07 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company appears highly valued given the size of its balance sheet.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last few months, analysts have been revising downwards their earnings forecast.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 9.73B | - | ||
+3.92% | 28.03B | B+ | ||
-8.25% | 2.11B | - | D | |
+2.35% | 1.41B | - | ||
-9.71% | 1.08B | - | C | |
+127.32% | 1.04B | B- | ||
+16.81% | 574M | B+ | ||
0.00% | 227M | - | - | |
-11.20% | 220M | - | ||
+27.76% | 205M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BARN Stock
- BARN N Stock
- Ratings Barry Callebaut AG